1436686-17-7 Usage
General Description
Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate is a chemical compound with the molecular formula C10H8BrN3O2. It is a derivative of the pyrazolopyrimidine family and is commonly used in pharmaceutical research and drug development. ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate has potential biological activities and is being investigated for its potential medicinal properties. It is also used as a building block in organic synthesis and as a research tool in chemical and biological studies. The compound's chemical structure and properties make it a valuable component in the development of new drugs and pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 1436686-17-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,6,6,8 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1436686-17:
(9*1)+(8*4)+(7*3)+(6*6)+(5*6)+(4*8)+(3*6)+(2*1)+(1*7)=187
187 % 10 = 7
So 1436686-17-7 is a valid CAS Registry Number.
1436686-17-7Relevant articles and documents
MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS AND USES THEREOF
-
Paragraph 249, (2019/05/30)
The present disclosure describes novel TRK kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such TRK kinase inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders are also described.
SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE
-
, (2015/06/03)
The present invention provides novel heterocyclic compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a JAK-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of JAK-mediated disease.
